NCT06748326 is a NA clinical trial of Laparoscopy in Intussusception, sponsored by Assiut University.

Who is sponsoring NCT06748326?

NCT06748326 is sponsored by Assiut University.

What drugs are being tested in NCT06748326?

Interventions in NCT06748326: Laparoscopy.

What condition does NCT06748326 study?

NCT06748326 studies Intussusception.

Is NCT06748326 still recruiting?

NCT06748326 is currently not yet recruiting. Last updated 4 February 2025.

Last reviewed 2025-02-04 · How we verify

NCT06748326

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laparoscopic Reduction of Intussusception in Children: Role in Primary Reduction After Failed Non-Surgical Therapies

Not yet recruiting NA Last updated 4 February 2025

What this trial tests

NA trial testing Laparoscopy in Intussusception in 20 participants. Not yet recruiting.

Timeline

3 May 2025

Primary endpoint
1 January 2026

1 March 2026

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	3 May 2025
Primary completion	1 January 2026
Estimated completion	1 March 2026

Drugs / interventions tested

Laparoscopy — full drug profile →

Conditions studied

Intussusception — all drugs for Intussusception →

Sponsor

Assiut University

Who can join

Adults 1 to 12, any sex, with Intussusception. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Laparoscopic Reduction of Intussusception in Children: Role in Primary Reduction after Failed Non-Surgical Therapies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Laparoscopy

Trials testing the same drug.

NCT07139951 — Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for the Treatment of Patients With Gastric and G · Phase 2 · enrolling by invitation
NCT04012710 — vNOTES for Salpingo-oophorectomy · NA · not yet recruiting
NCT06187844 — Value of Inguinal Exploration for Impalpable Testes · NA · unknown
NCT06132087 — PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemothe · NA · active not recruiting
NCT06109545 — Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy · unknown

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06748326 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 4 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06748326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing